menu search

: palantir quickly reverses higher toward a 3-month high, best 4-day gain in six months

Shares of Palantir Technologies Inc. PLTR quickly reversed an early pullback to power up 4.0% toward a ...

November 4, 2023, 4:29 pm

Atmus filtration technologies inc. (atmu) q3 2023 earnings call transcript

Atmus Filtration Technologies Inc. (ATMU) Q3 2023 Earnings Call Transcript...

November 4, 2023, 12:02 pm

Cps technologies corporation (cpsh) q3 2023 earnings call transcript

CPS Technologies Corporation (NASDAQ:CPSH ) Q3 2023 Results Conference Call November 2, 2023 9:00 AM ET...

November 4, 2023, 11:59 am

Faro technologies, inc. (faro) q3 2023 earnings call transcript

FARO Technologies, Inc. (NASDAQ:FARO ) Q3 2023 Results Conference Call November 2, 2023 8:00 AM ET Comp...

November 4, 2023, 11:50 am

Here's why cognex stock crashed in october

Consumer electronics, logistics, and automotive spending plans have been held back in 2023. The company's techn...

November 4, 2023, 10:58 am

Enviri corporation (nvri) q3 2023 earnings call transcript

Enviri Corporation (NYSE:NVRI ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants David Martin - Director of Investor ...

November 4, 2023, 10:24 am

Biden's ai executive order: it's about understanding this technology, the risks, says c3.ai ceo

President Biden signed into action a sweeping executive order to promote innovation in artificial intelligence while also seeking to enforce effective...

November 4, 2023, 9:00 am

Palantir q3 earnings: focus on government contracts (rating upgrade)

Palantir Technologies reported strong Q3 2023 earnings, indicating significant upside potential for inv...

November 4, 2023, 7:28 am

Sedg investor alert: robbins geller rudman & dowd llp announces that solaredge technologies, inc. investors with substantial losses have opportunity to lead the solaredge class action lawsuit

SAN DIEGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of SolarEdge Techn...

November 4, 2023, 2:55 am

Investors sue solaredge technologies (sedg) for stocking up channels with excess inventory– hagens berman

Firm Encourages Investors with Losses to Contact its Attorneys SAN FRANCISCO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges SolarEdge Techn...

November 4, 2023, 2:17 am

Micron is positioned to enjoy the semiconductors next cycle

Micron is an attractive investment opportunity in the information technology sector, operating in the g...

November 4, 2023, 1:39 am

10x genomics: unveiling the investment potential

10x Genomics is a life science technology company with a clear mission and visionary leadership. 10x Ge...

November 4, 2023, 1:02 am

U.s. ipo weekly recap: biotech lexeo stumbles after $100 million ipo

Two IPOs are currently scheduled for the week ahead, although some small issuers may join the calendar late. As of 11/2/2023, the Renaissance IPO Inde...

November 4, 2023, 12:21 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Rosen, national trial lawyers, encourages purecycle technologies, inc. investors to secure counsel before important deadline in securities class action – pct, pcttw, pcttu

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PureCycle Tec...

November 3, 2023, 11:20 pm

Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl

This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLOBE NEWSW...

November 3, 2023, 11:10 pm

Bectran to sponsor credit research foundation’s november forum as a platinum partner

CHICAGO, Nov. 03, 2023 (GLOBE NEWSWIRE) — Bectran, Inc., the industry leader in innovative, cutting-edge techn...

November 3, 2023, 9:31 pm


Search within

Pages Search Results: